These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29140530)

  • 1. Antipsychotic Combinations for Schizophrenia.
    Ortiz-Orendain J; Castiello-de Obeso S; Colunga-Lozano L; Hu Y; Maayan N; Adams C
    Schizophr Bull; 2018 Jan; 44(1):15-17. PubMed ID: 29140530
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
    Gazdag G; Tolna J; Bitter I
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute respiratory distress due to antipsychotic drugs.
    Yagmur F; Ulusoy HB; Buyukoglan H; Kaya MG
    Pharmacopsychiatry; 2010 May; 43(3):118-9. PubMed ID: 20446229
    [No Abstract]   [Full Text] [Related]  

  • 4. Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Borlido C; Remington G; Graff-Guerrero A; Arenovich T; Hazra M; Wong A; Daskalakis ZJ; Mamo DC
    J Clin Psychiatry; 2016 Jan; 77(1):e14-20. PubMed ID: 26845273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An importance of dose in antipsychotic combination therapy for schizophrenia.
    Suzuki T
    J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
    [No Abstract]   [Full Text] [Related]  

  • 6. Unbalanced statistical analysis of combined divalproex and antipsychotic therapy for schizophrenia.
    Boylan LS; Labovitz DL
    Neuropsychopharmacology; 2004 Mar; 29(3):636; author reply 637-8. PubMed ID: 14973433
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia.
    Liu HC; Hung GC; Yang SY; Liao YT; Pan CH; Chen CC; Kuo CJ
    Psychiatry Clin Neurosci; 2018 Oct; 72(10):789-800. PubMed ID: 29987915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs--an update.
    Charalampous KD; Keepers GA
    J Okla State Med Assoc; 1978 Jan; 71(1):6-9. PubMed ID: 23420
    [No Abstract]   [Full Text] [Related]  

  • 9. Central atropine-like toxicity in combined psychotropic drug administration.
    el-Yousef MK; Davis JM; Janowsky DS; Fann WE
    J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic polypharmacy: never say never, but never say always.
    Stahl SM
    Acta Psychiatr Scand; 2012 May; 125(5):349-51. PubMed ID: 22506490
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues in polypharmacotherapy: focus on depression in schizophrenia.
    Dufresne RL
    Psychopharmacol Bull; 1995; 31(4):789-96. PubMed ID: 8851655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of schizophrenia. The Expert Consensus Panel for Schizophrenia.
    J Clin Psychiatry; 1996; 57 Suppl 12B():3-58. PubMed ID: 8946807
    [No Abstract]   [Full Text] [Related]  

  • 13. Should patients with schizophrenia receive antidepressants?
    Terevnikov V; Stenberg JH; Joffe G
    Duodecim; 2017; 133(5):465-71. PubMed ID: 29205993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam-neuroleptic combination in schizophrenia.
    Lipinski JF; Cohen BM
    Am J Psychiatry; 1986 Nov; 143(11):1501-2. PubMed ID: 2877587
    [No Abstract]   [Full Text] [Related]  

  • 15. The choice of drugs for schizophrenia.
    Davis JM
    N Engl J Med; 2006 Feb; 354(5):518-20. PubMed ID: 16452565
    [No Abstract]   [Full Text] [Related]  

  • 16. Focus on polypharmacy in schizophrenia: does anyone truly benefit?
    Goff DC; Freudenreich O
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):109-11. PubMed ID: 15137932
    [No Abstract]   [Full Text] [Related]  

  • 17. The need to determine the best options for people with schizophrenia that is unresponsive to treatment.
    Stroup TS
    Rev Psiquiatr Salud Ment; 2013; 6(1):1-3. PubMed ID: 23084800
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined alprazolam and neuroleptic drug in treating schizophrenia.
    Bacher NM; Lewis HA; Field PB
    Am J Psychiatry; 1986 Oct; 143(10):1311-3. PubMed ID: 2876649
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment outlines for schizophrenia.
    Aust N Z J Psychiatry; 1984 Sep; 18(3):287-9. PubMed ID: 6148929
    [No Abstract]   [Full Text] [Related]  

  • 20. Alprazolam augmentation of neuroleptics in schizophrenia.
    Wolkowitz OM; Breier A; Doran A; Lucas P; Kelsoe J; Paul SM; Pickar D
    Am J Psychiatry; 1989 Aug; 146(8):1087-8. PubMed ID: 2568762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.